Valuation : Tsumura & Co.

Market Cap 282B 1.76B 1.52B 1.42B 1.3B 2.45B 169B 2.46B 16.9B 6.59B 85.07B 6.62B 6.48B P/E 2027 *
10.8x
P/E 2028 * 10.4x
Enterprise Value 380B 2.37B 2.04B 1.92B 1.75B 3.3B 227B 3.31B 22.75B 8.88B 114B 8.91B 8.72B EV / Sales 2027 *
1.76x
EV / Sales 2028 * 1.83x
Free-Float
90.5%
Yield 2027 *
4.18%
Yield 2028 * 4.57%
1 day-1.18%
1 week+0.45%
Current month-0.86%
1 month-6.45%
3 months-0.68%
6 months-9.69%
Current year-7.19%
1 week 3,762
Extreme 3762
3,870
1 month 3,702
Extreme 3702
3,917
Current year 3,513
Extreme 3513
4,403
1 year 3,444
Extreme 3444
4,403
3 years 2,580
Extreme 2580
5,138
5 years 2,536
Extreme 2536
5,138
10 years 2,189
Extreme 2189
5,138
Manager TitleAgeSince
Chief Executive Officer 63 2019-05-31
Director of Finance/CFO - -
Chief Operating Officer 56 2022-03-31
Director TitleAgeSince
Director/Board Member 63 2011-05-31
Director/Board Member 77 2018-05-31
Director/Board Member 70 2020-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.18%+0.45%+6.86%+38.03% 1.76B
-0.13%-6.44%+60.34%+112.06% 1,047B
+0.85%-0.81%+51.29%+63.13% 646B
-1.03%-3.58%+21.43%+73.10% 451B
-1.46%-4.50%+37.80%+37.41% 355B
-0.72%-2.89%+22.32%+36.62% 291B
-1.19%-2.21%+1.53%+10.79% 252B
-1.05%-1.57%+50.30%+66.55% 234B
+0.08%-1.78%-17.64%-54.36% 203B
-2.14%-0.30%+28.95%+86.27% 181B
Average -0.80%-2.36%+26.32%+46.96% 366.1B
Weighted average by Cap. -0.46%-3.46%+38.16%+64.99%

Financials

2027 *2028 *
Net sales 215B 1.34B 1.16B 1.09B 992M 1.87B 129B 1.87B 12.89B 5.03B 64.88B 5.05B 4.94B 229B 1.43B 1.23B 1.16B 1.06B 1.99B 137B 1.99B 13.72B 5.35B 69.03B 5.37B 5.26B
Net income 26.07B 163M 140M 132M 120M 226M 15.58B 227M 1.56B 610M 7.86B 612M 599M 27.03B 169M 146M 137M 125M 235M 16.15B 236M 1.62B 632M 8.15B 634M 621M
Net Debt 97.56B 610M 526M 493M 450M 847M 58.29B 850M 5.85B 2.28B 29.42B 2.29B 2.24B 136B 853M 735M 689M 629M 1.18B 81.51B 1.19B 8.18B 3.19B 41.15B 3.2B 3.13B
Logo Tsumura & Co.
Tsumura & Co is a Japan-based company mainly engaged in manufacturing and sales of prescription drugs and over-the-counter drugs. The Company operates the Pharmaceuticals segment. In Japan, the Company conducts the manufacturing, sales, transportation and storage of prescription drugs and over-the-counter drugs, and cultivation, procurement, selection, processing and storage of raw medicinal herbs. In China, the Company is engaged in regional management, business management, production and sales of herbal extract powders, cultivation, procurement, selection, processing and storage of herbal ingredients, and sales of pharmaceuticals and food products. In Laos, the Company is engaged in cultivation, procurement, selection, processing and storage of herbal ingredients. In the United States, the Company is engaged in pharmaceutical development business.
Employees
4,923
Date Price Change Volume
26-08-28 JP¥3,784.00 -1.18% 362,500
26-08-27 JP¥3,829.00 +0.66% 456,800
26-08-26 JP¥3,804.00 +0.56% 416,400
26-08-25 JP¥3,783.00 +0.32% 506,000
26-08-24 JP¥3,771.00 +0.11% 332,700
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
3,784.00JPY
Average target price
4,342.50JPY
Spread / Average Target
+14.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4540 Stock